DrugPatentWatch
Uses AIPredict Generic Entry, Patent Risk, and Revenue Shifts Before Your Competitors
drugpatentwatch.com Data & Analytics / Market & Competitive Intelligence
- Monthly visits
- 47.7K
- Down21.1%MoMSep 2026
- Public revenue
- Undisclosed
- No public revenue evidence yet
- Entry price
- $1000/mo
- Higher than 98% of peersNiche median $25/mo
- Launched
- 9y ago
- 2017-11-16 · Est.
Traffic
Marketing moves
Launches, search & content, referrals, promotions- The Forum You File In Changes Your Odds More Than the Merits Do https://www.drugpatentwatch.com/blog/the-forum-you-file-in-changes-your-odds-more-than-the-merits-do/
@drugpatentwatch · 2026-11-02 · 0 likes · 0 reposts · 67 views
- The Supply Agreement Clause Nobody Negotiates: What Happens When the Patent Gets Invalidated Early https://www.drugpatentwatch.com/blog/the-supply-agreement-clause-nobody-negotiates-what-happens-when-the-patent-gets-invalidated-early/
@drugpatentwatch · 2026-11-02 · 0 likes · 0 reposts · 51 views
- Cut Drug R&D Costs by 90%: The 505(b)(2) Playbook the Big Pharma Textbook Ignores https://www.drugpatentwatch.com/blog/cut-drug-rd-costs-by-90-the-505b2-playbook-the-big-pharma-textbook-ignores
@drugpatentwatch · 2026-11-02 · 0 likes · 0 reposts · 73 views
Launched on Product HuntLaunch
Track drug patent expirations & other market-shaping events
Aug 3, 2020 · 6y agoLaunch page
Launched on Product HuntLaunch
Biopharmaceutical business intelligence
Nov 16, 2017 · 9y agoLaunch page
Traffic sources
Traffic breakdown
Channels
- Organic Search57%
- Direct23%
- Referrals8%
- AI Assistants6%
- Other6%
Countries
- United States37%
- India8%
- South Africa8%
- United Kingdom7%
- Brazil3%
Search
Domain authority —Domain registered 2005-01-03
| Keyword | Monthly volume |
|---|---|
| valbenazina por que é tão caro | 510 |
| drugpatentwatch | 240 |
| drug patent watch 2026 gmp costs | 180 |
| best way to structure licensed drug royalty arrangement | — |
| how long is the patent period for drugs | — |
Traffic data: Vaneform
Pricing
Trial: None · 2 paid tiers ($1000–$3000) · Up to 33% off annually · Enterprise custom tier · Observed 2026-11-05 · Pricing page
Entry price $1000/mo, Higher than 98% of peers; “Market & Competitive Intelligence” median is $25/mo.View pricing benchmark
Pages & changes
Key pages
Weekly snapshots- Homewww.drugpatentwatch.com/
- Pricingwww.drugpatentwatch.com/pricing/ Snapshot 2026-11-05
Changes
Design
Editorial (Dark canvas, airy density) featuring centered headline + cta layout and pure typography & geometry visuals.
First-screen preview · click to zoom
First-screen pitch & conversion flow
“Predict Generic Entry, Patent Risk, and Revenue Shifts Before Your Competitors”
Centered Headline + CTA hero structure paired with start free / sign up CTA and user count, rating, or key metrics.
Conversion path: Centered Headline + CTA + Pure Typography & Geometry → Start Free / Sign Up · Trust bar: User Count, Rating, or Key Metrics
- Outcome & Speed Promise
- Metrics Strip
Palette · click to copy
- Typography
- 8.0
- Color & Contrast
- 8.0
- Layout & Spacing
- 7.0
- Craft & Polish
- 7.0
- Distinctiveness
- 6.0
Structure
- Fonts
- Playfair Display / Inter
- Hero layout
- Centered Headline + CTA
- Primary visual
- Pure Typography & Geometry
- Conversion CTA
- Start Free / Sign Up
- Social proof
- User Count, Rating, or Key Metrics
- Navigation
- Full-Width Top Bar
- Theme & density
- Dark · Airy
- Corners & depth
- Medium Radius · With shadow
Preview full AI design brief (includes :root CSS variables & layout rules)Style tokens only; never copy brand names, logos, copy, or images
# Design Brief: Editorial (with Enterprise Clean)
Oversized serif headlines, narrow reading columns, and magazine-inspired grid layouts.
## Design Tokens
```css
:root {
--background: #071525;
--surface: #102033;
--foreground: #f3efe6;
--muted-foreground: #9aa8b5;
--accent: #1aa88a;
--radius: 8px;
--font-heading: "Playfair Display", ui-sans-serif, system-ui, sans-serif;
--font-body: "Inter", ui-sans-serif, system-ui, sans-serif;
}
```
Color area ratio: Background #071525 (~72%) · Surface #102033 (~8%) · Text #F3EFE6 (~10%) · Muted Text #9AA8B5 (~5%) · Accent #1AA88A (~5%). Background and surface dominate the canvas; reserve the accent color for primary buttons and active states.
## Layout & Conversion Structure
- Hero layout: Centered Headline + CTA
- Navigation: Full-Width Top Bar
- Theme & density: Dark · Airy
- Border radius & elevation: Medium Radius; use elevation shadows to separate layers
- Primary visual medium: Pure Typography & Geometry
- Conversion CTA: Start Free / Sign Up · Trust bar uses User Count, Rating, or Key Metrics
- Headline hook: Outcome & Speed Promise
- Hero components: Metrics Strip
- Spatial layout notes: Centered Headline + CTA hero structure paired with start free / sign up CTA and user count, rating, or key metrics.
- Visual summary: Editorial (Dark canvas, airy density) featuring centered headline + cta layout and pure typography & geometry visuals.
## Avoid
- Generic SaaS hero templates
- Cramped multi-column feature grids
- Neon cyber accents
Implement the UI following the design tokens and layout specifications above: use only these color variables, and reserve the accent color strictly for primary actions and active states. Adopt only this visual style—never copy any reference product’s brand name, logo, copy, or imagery.
Questions & evidence
- How much does DrugPatentWatch cost?
- Starter: $1,000/mo (annual billing available); Professional: $3,000/mo (annual billing available); Enterprise: Contact sales. Observed 2026-11-05. Check the source for current billing terms, usage limits and taxes.Source
- How much website traffic does DrugPatentWatch get?
- Vaneform estimates 47.7K website visits in 2026-09. Visits can include repeat visits; this estimate does not measure paying customers or revenue.Source
Related products in this category
These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.
| Product | Entry price | Visits | Revenue |
|---|---|---|---|
| DolphinRadarGiantYour All-in-One Instagram Tool | $2.75/mo | 13.3M | Undisclosed |
| ArtificialAnalysisGiantAI Model & API Providers Analysis | $417/mo | 11.2M | Undisclosed |
| OSIRISSelf-hosting guide, interface reference, and the complete API reference for all 57 OSIRIS endpoints. | — | 4.3M | Undisclosed |
| AppBrainLook up any app | $75/mo | 4M | Undisclosed |
| TracxnTechnology + Human-in-the-Loop for Deal Discovery | — | 3M | Undisclosed |
| CrunchbaseBefore It's News, It's In Crunchbase | — | 2.9M | Undisclosed |